I am a
Home I AM A Search Login

Papers of the Week

Papers: 1 May 2021 - 7 May 2021

Human Studies, Pharmacology/Drug Development


2021 May 03

J Headache Pain



Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study).


Vernieri F, Altamura C, Brunelli N, Costa C M, Aurilia C, Egeo G, Fofi L, Favoni V, Pierangeli G, Lovati C, Aguggia M, d'Onofrio F, Doretti A, Di Fiore P, Finocchi C, Rao R, Bono F, Ranieri A, Albanese M, Cevoli S, et al.
J Headache Pain. 2021 May 03; 22(1):35.
PMID: 33941080.


The clinical benefit of galcanezumab, demonstrated in randomized clinical trials (RCTs), remains to be quantified in real life. This study aimed at evaluating the effectiveness, safety and tolerability of galcanezumab in the prevention of high-frequency episodic migraine (HFEM) and chronic migraine (CM) in a real-life setting.